GENMAB i Radio24/7
-
Jeg nåede langt omkring selskabet; Dara og resultatet af Fase II, handelsmønsteret de seneste dage med stoploss-raid, ADR og sidst i udsendelsen lidt om fremtiden.
-
GENMAB - Kommentar på Børsen Play TV i morges:
-
GENMAB-instrumentet ADR er vist ikke altid billigere. Det er vist kun i helt usædvanlige situationer, at den svinger væk fra den danske pris.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind